JAK inhibitors and VTE risk: how concerned should we be?

被引:14
|
作者
Cohen, Stanley B. [1 ,2 ]
机构
[1] THR Presbyterian Hosp, Metroplex Clin Res Ctr, Dept Rheumatol, Dallas, TX 75231 USA
[2] Univ Texas Southwestern Med Sch, Dallas, TX 75390 USA
关键词
RHEUMATOID-ARTHRITIS; SAFETY PROFILE; THROMBOSIS;
D O I
10.1038/s41584-021-00575-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Janus kinase (JAK) inhibitors have become standard treatment for patients with rheumatoid arthritis who do not respond well to other DMARDs. Concerns have been raised over an increased risk of venous thromboembolism with JAK inhibitors, tempering enthusiasm for their use in the clinic, but are these concerns justified?
引用
收藏
页码:133 / 134
页数:2
相关论文
共 50 条
  • [21] Single-use duodenoscopes: How concerned should we be about the environment?
    Pohl, Heiko
    [J]. GASTROINTESTINAL ENDOSCOPY, 2022, 96 (06) : 1009 - 1011
  • [22] Leptospirosis and Coinfection: Should We Be Concerned?
    Md-Lasim, Asmalia
    Mohd-Taib, Farah Shafawati
    Abdul-Halim, Mardani
    Mohd-Ngesom, Ahmad Mohiddin
    Nathan, Sheila
    Md-Nor, Shukor
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (17)
  • [23] ASAP and HGPIN: Should We Be Concerned?
    Srirangam, V.
    Rai, B. P.
    Abroaf, A.
    Agarwal, S.
    Tadtayev, S.
    Foley, C.
    Lane, T.
    Adshead, J.
    Vasdev, N.
    [J]. JOURNAL OF PATHOLOGY, 2017, 241 : S13 - S13
  • [24] Fatty Pancreas Should We Be Concerned?
    Majumder, Shounak
    Philip, Nissy A.
    Takahashi, Naoki
    Levy, Michael J.
    Singh, Vijay P.
    Chari, Suresh T.
    [J]. PANCREAS, 2017, 46 (10) : 1251 - 1258
  • [25] Brain changes after COVID-19 — how concerned should we be?
    Stéphane Kremer
    H. Rolf Jäger
    [J]. Nature Reviews Neurology, 2022, 18 : 321 - 322
  • [26] How concerned should we be about missing antibodies to low incidence antigens?
    Garratty, G
    [J]. TRANSFUSION, 2003, 43 (07) : 844 - 847
  • [27] Brain changes after COVID-19-how concerned should we be?
    Kremer, Stephane
    Jager, H. Rolf
    [J]. NATURE REVIEWS NEUROLOGY, 2022, 18 (06) : 321 - 322
  • [28] The cost of COX inhibitors: How selective should we be?
    Marra, CA
    Esdaile, JM
    Sun, HY
    Anis, AH
    [J]. JOURNAL OF RHEUMATOLOGY, 2000, 27 (12) : 2731 - 2733
  • [29] How should we use ALK inhibitors separately?
    Seto, Takashi
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [30] Breast cancer risk after oocyte donation: should we really be concerned?
    Fauser, Bart C. J. M.
    Velasco, Juan Garcia
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2017, 34 (05) : 439 - 440